Login
Home
Charts
Search
Watchlist
Products

Aristo Bio-Tech & Lifescience Ltd

ARISTO·NSE
112.000.00%Tue, 22 Sept '26

Aristo Bio-Tech & Lifescience Ltd

ARISTO
NSE
112.00
0.00%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
76Cr
Close
Close Price
112.00
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
10.62
PS
Price To Sales
0.21
Revenue
Revenue
364Cr
Rev Gr TTM
Revenue Growth TTM
14.34%
PAT Gr TTM
PAT Growth TTM
76.91%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
937312989133112214104256107
Growth YoY
Revenue Growth YoY%
39.321.52.926.561.2-7.519.83.2
Expenses
ExpensesCr
88721248512810920610324999
Operating Profit
Operating ProfitCr
4154538188
OPM
OPM%
4.71.23.94.14.02.93.81.13.17.6
Other Income
Other IncomeCr
0000000000
Interest Expense
Interest ExpenseCr
1112111113
Depreciation
DepreciationCr
1111111111
PBT
PBTCr
3042437176
Tax
TaxCr
1010111011
PAT
PATCr
2031315043
Growth YoY
PAT Growth YoY%
46.3403.0-0.832.077.0-137.1-8.3714.3
NPM
NPM%
1.9-0.52.01.11.91.22.1-0.51.62.8
EPS
EPS
0.00.00.01.53.81.96.7-0.76.14.4
QuarterSep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
937312989133112214104256107
Growth YoY
Revenue Growth YoY%
39.321.52.926.561.2-7.519.83.2
Expenses
ExpensesCr
88721248512810920610324999
Operating Profit
Operating ProfitCr
4154538188
OPM
OPM%
4.71.23.94.14.02.93.81.13.17.6
Other Income
Other IncomeCr
0000000000
Interest Expense
Interest ExpenseCr
1112111113
Depreciation
DepreciationCr
1111111111
PBT
PBTCr
3042437176
Tax
TaxCr
1010111011
PAT
PATCr
2031315043
Growth YoY
PAT Growth YoY%
46.3403.0-0.832.077.0-137.1-8.3714.3
NPM
NPM%
1.9-0.52.01.11.91.22.1-0.51.62.8
EPS
EPS
0.00.00.01.53.81.96.7-0.76.14.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
57160271202201167166218245318364
Growth
Revenue Growth%
180.369.6-25.7-0.2-16.9-0.731.312.529.814.3
Expenses
ExpensesCr
56158264195197163161209237309348
Operating Profit
Operating ProfitCr
137754598916
OPM
OPM%
1.61.62.73.42.22.63.34.03.52.94.4
Other Income
Other IncomeCr
01100000000
Interest Expense
Interest ExpenseCr
01223223224
Depreciation
DepreciationCr
00011112233
PBT
PBTCr
136412255510
Tax
TaxCr
01210011213
PAT
PATCr
02431114447
Growth
PAT Growth%
365.3101.9-24.3-64.46.835.9143.79.44.376.8
NPM
NPM%
0.71.21.41.40.50.60.91.61.61.32.0
EPS
EPS
4.018.537.45.72.02.12.95.25.76.010.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
57160271202201167166218245318364
Growth
Revenue Growth%
180.369.6-25.7-0.2-16.9-0.731.312.529.814.3
Expenses
ExpensesCr
56158264195197163161209237309348
Operating Profit
Operating ProfitCr
137754598916
OPM
OPM%
1.61.62.73.42.22.63.34.03.52.94.4
Other Income
Other IncomeCr
01100000000
Interest Expense
Interest ExpenseCr
01223223224
Depreciation
DepreciationCr
00011112233
PBT
PBTCr
136412255510
Tax
TaxCr
01210011213
PAT
PATCr
02431114447
Growth
PAT Growth%
365.3101.9-24.3-64.46.835.9143.79.44.376.8
NPM
NPM%
0.71.21.41.40.50.60.91.61.61.32.0
EPS
EPS
4.018.537.45.72.02.12.95.25.76.010.6

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
11155557777
Reserves
ReservesCr
2476781023273137
Current Liabilities
Current LiabilitiesCr
24787072655651598496103
Non Current Liabilities
Non Current LiabilitiesCr
05117111211101088
Total Liabilities
Total LiabilitiesCr
27878991888177100127141155
Current Assets
Current AssetsCr
2584818177696383105116130
Non Current Assets
Non Current AssetsCr
2381011121417222525
Total Assets
Total AssetsCr
27878991888177100127141155
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
11155557777
Reserves
ReservesCr
2476781023273137
Current Liabilities
Current LiabilitiesCr
24787072655651598496103
Non Current Liabilities
Non Current LiabilitiesCr
05117111211101088
Total Liabilities
Total LiabilitiesCr
27878991888177100127141155
Current Assets
Current AssetsCr
2584818177696383105116130
Non Current Assets
Non Current AssetsCr
2381011121417222525
Total Assets
Total AssetsCr
27878991888177100127141155

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1-418127-38109
Investing Cash Flow
Investing Cash FlowCr
00-5-2-2-2-3-4-7-5-3
Financing Cash Flow
Financing Cash FlowCr
044-61-1-38-2-4-4
Net Cash Flow
Net Cash FlowCr
00000001-102
Free Cash Flow
Free Cash FlowCr
0-408114-5156
CFO To PAT
CFO To PAT%
155.4-214.622.8288.1139.7212.3466.9-78.1195.1246.5123.3
CFO To EBITDA
CFO To EBITDA%
65.9-157.511.6119.531.252.6125.0-32.089.5108.055.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1-418127-38109
Investing Cash Flow
Investing Cash FlowCr
00-5-2-2-2-3-4-7-5-3
Financing Cash Flow
Financing Cash FlowCr
044-61-1-38-2-4-4
Net Cash Flow
Net Cash FlowCr
00000001-102
Free Cash Flow
Free Cash FlowCr
0-408114-5156
CFO To PAT
CFO To PAT%
155.4-214.622.8288.1139.7212.3466.9-78.1195.1246.5123.3
CFO To EBITDA
CFO To EBITDA%
65.9-157.511.6119.531.252.6125.0-32.089.5108.055.1

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3843795176
Price To Earnings
Price To Earnings
10.710.919.57.110.6
Price To Sales
Price To Sales
0.20.20.30.10.2
Price To Book
Price To Book
1.31.32.11.21.7
EV To EBITDA
EV To EBITDA
6.87.410.85.26.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
10.06.97.17.85.87.99.98.25.85.06.76.7
OPM
OPM%
1.61.62.73.42.22.63.34.03.52.94.44.4
NPM
NPM%
0.71.21.41.40.50.60.91.61.61.32.02.0
ROCE
ROCE%
14.223.626.124.713.110.410.914.213.012.017.117.1
ROE
ROE%
13.839.144.125.08.28.09.811.811.610.916.316.3
ROA
ROA%
1.52.14.23.11.11.31.93.63.12.94.64.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3843795176
Price To Earnings
Price To Earnings
10.710.919.57.110.6
Price To Sales
Price To Sales
0.20.20.30.10.2
Price To Book
Price To Book
1.31.32.11.21.7
EV To EBITDA
EV To EBITDA
6.87.410.85.26.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
10.06.97.17.85.87.99.98.25.85.06.76.7
OPM
OPM%
1.61.62.73.42.22.63.34.03.52.94.44.4
NPM
NPM%
0.71.21.41.40.50.60.91.61.61.32.02.0
ROCE
ROCE%
14.223.626.124.713.110.410.914.213.012.017.117.1
ROE
ROE%
13.839.144.125.08.28.09.811.811.610.916.316.3
ROA
ROA%
1.52.14.23.11.11.31.93.63.12.94.64.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Aristo Bio-Tech & Lifescience Ltd is a dedicated Indian crop protection company that makes the chemicals farmers use to stop insects, weeds and fungus from destroying their harvest - a problem that still claims roughly a third of India’s annual crop yield. Founded in 2005 as a private company in Maharashtra and now listed on the NSE Emerge platform, it has spent two decades building a single, focused factory in Gujarat that does two things under one roof: it formulates its own branded pesticides and it runs the same production lines for some of the world’s largest agrochemical companies on a contract basis. The recurring approach is simple - own one certified manufacturing site, register as many product approvals as possible with the regulator, and sell the output both across India and to export markets, so that the same plant and the same quality-control lab serve every customer. # Business segments A single engine - a pesticide formulation and contract manufacturing plant in Gujarat - that reaches farmers through its own branded products and serves multinationals through job-work agreements, all from the same factory floor. ## 1. Agrochemical formulation and manufacturing: the factory that works for everyone **One ISO-certified plant in Vadodara makes insecticides, herbicides, fungicides and plant growth regulators, then sells them under the company’s own registrations or under a customer’s label - same machines, same quality lab, two revenue streams.** - **Own-brand sales across 20 states** - the company holds 257 product registrations from India’s Central Insecticides Board, up from 182 two years earlier, which gives it the legal right to manufacture and sell those formulations under its own name to a network of dealers, distributors and retailers spanning every major agricultural state from Punjab to Tamil Nadu. - **Contract manufacturing for industry names** - the same production lines also run batches for Sinochem, Syngenta, National Fertilizers, Rotam and Albaugh LLC, among others, meaning the company earns a manufacturing fee without having to build a separate brand or distribution channel for those volumes. - **One facility, every step in-house** - the company’s plant houses formulation, packaging, and a quality-control lab equipped with HPLC, UV and GC testing instruments, so raw materials, finished goods and even packaging materials like HDPE bottles and laminated pouches are tested on site against FAO and BIS standards before release. - **Exports to 15 countries via a bill-to-ship-to model** - goods move directly from the supplier’s country to the buyer’s country without entering India, which keeps the transaction outside Indian GST and lets the company serve markets from Australia and Germany to Kenya and Vietnam without adding domestic logistics cost. # Group structure and partners **A promoter-led company with no subsidiaries and no foreign collaborations - the business runs through one listed entity, three associate firms, and a six-member board.** - **Standalone entity** - the company has no subsidiary, associate or joint venture company, so all manufacturing, sales and regulatory licences sit inside the listed entity itself. - **Three associate firms** - Orchid Agro System, Kinlak Biotech and Indus Findem LLP are related parties; in FY24 the company sold roughly Rs. 5.3 crore of product to the first two and bought about Rs. 2.4 crore from Orchid Agro System, making them both customers and a supplier. - **Promoter leadership** - Chairman and Managing Director Narendra Singh Barhat and Executive Director Kusum Barhat have run the business since incorporation in 2005, with Mrs. Barhat overseeing management and human resources across the company’s 66 employees. - **NSE Emerge listing** - the company’s shares trade on the NSE’s SME platform, which exempts it from the full corporate governance regulations that apply to main-board companies.

Documents — Aristo Bio-Tech & Lifescience Ltd

  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/0cs3yxxd1wbjrqbkf5e1rapj.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/n47z1zfokg9axatmwzgj9ja6.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ehgmo4087eczds3rxg9g8i7u.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/yu163t8iu4h2ojyi630ha3at.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/xe6fis3b6b4tjmrsx5ndpmn0.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/auo955emp27fogp3weoxb7gu.pdf